PubRank

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes (CSET 1437)

Clinical Trial ID NCT01159288

PubWeight™ 20.87‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01159288

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013 2.46
2 Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology 2015 1.53
3 Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology 2012 1.51
4 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
5 Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles 2015 1.30
6 Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol 2014 1.29
7 Targeting metastasis. Nat Rev Cancer 2016 1.26
8 Molecular pathways and therapeutic targets in lung cancer. Oncotarget 2014 1.16
9 Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles 2015 1.11
10 Cancer/testis antigens and urological malignancies. Nat Rev Urol 2012 1.01
11 The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy 2015 1.00
12 Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget 2015 0.94
13 Antigen-specific vaccines for cancer treatment. Hum Vaccin Immunother 2014 0.89
14 Optimizing dendritic cell-based approaches for cancer immunotherapy. Yale J Biol Med 2014 0.85
15 Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy. Front Immunol 2015 0.82
16 Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Rev Clin Immunol 2014 0.79
17 Exosomes as renal inductive signals in health and disease, and their application as diagnostic markers and therapeutic agents. Front Cell Dev Biol 2015 0.79
18 Texosome-based drug delivery system for cancer therapy: from past to present. Cancer Biol Med 2015 0.76
19 Cancer testis antigen and immunotherapy. Immunotargets Ther 2013 0.76
20 The Fourth International Meeting of ISEV, ISEV2015. J Extracell Vesicles 2015 0.75
Next 100